Clinical Trial Detail

NCT ID NCT02637375
Title A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements yes
Sponsors University of Chicago
Indications

triple-receptor negative breast cancer

Therapies

Cyclophosphamide + Doxorubicin + Paclitaxel

Ganetespib

Age Groups: adult

Additional content available in CKB BOOST